# Boston Scientific to acquire Silk Road Medical for $1.16 billion

Boston Scientific agreed to acquire Silk Road Medical, a medical device company focused on stroke prevention via the TCAR procedure, for $27.50 per share, enterprise value of approximately $1.16 billion.

- Type: Acquisition
- Announced: 2024-06-18
- Where: United States
- Value: $1.16B
- Status: announced
- Products: TCAR system, carotid artery stents
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boston Scientific](https://endata.com/companies/15966.md) (acquirer)
- [Silk Road Medical](https://endata.com/companies/76145.md) (target)

## Sources

- [news.bostonscientific.com](https://news.bostonscientific.com/2024-06-18-Boston-Scientific-Announces-Agreement-to-Acquire-Silk-Road-Medical,-Inc), 2024-06-18: "The TCAR platform developed by Silk Road Medical is a notable advancement in the field of vascular medicine"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.